Logo image of CGEM

CULLINAN THERAPEUTICS INC (CGEM) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CGEM - US2300311063 - Common Stock

10.37 USD
+0.11 (+1.07%)
Last: 12/26/2025, 8:00:00 PM
10.37 USD
0 (0%)
After Hours: 12/26/2025, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
CGEM revenue by date.CGEM revenue by date.
18.94M141.16M
-100.00%
25.083M24.116M
-3.86%
21.191M
-12.13%
134.55M
534.94%
325.73M
142.09%
825.3M
153.37%
EBITDA
YoY % growth
CGEM ebitda by date.CGEM ebitda by date.
-22.2M
-52.58%
-60.28M
-171.53%
-67.9M
-12.64%
147.98M
-91.53%
-195.671M
-46.36%
-198.123M
-3.30%
-229.155M
-16.55%
-185.976M
18.84%
-163.261M
12.21%
N/AN/AN/AN/A
EBIT
YoY % growth
CGEM ebit by date.CGEM ebit by date.
-22.27M
-52.64%
-60.34M
-170.95%
-67.95M
-12.61%
148.39M
-91.52%
-196.334M
-46.50%
-197.881M
-3.29%
-245.293M
-24.57%
-212.739M
13.27%
-229.103M
-7.69%
-282.059M
-23.11%
-268.728M
4.73%
-150.772M
43.89%
206.51M
236.97%
Operating Margin
CGEM operating margin by date.CGEM operating margin by date.
N/AN/A-358.76%105.12%N/AN/AN/A-848.14%-950.00%-1,331.03%-199.72%-46.29%25.02%
EPS
YoY % growth
CGEM eps by date.CGEM eps by date.
N/AN/A-1.50
9.41%
2.38
258.00%
-4.17
-255.70%
-3.12
17.89%
-3.60
-18.83%
-3.09
14.22%
-2.73
11.54%
-3.43
-25.44%
-3.18
7.14%
0.03
100.96%
2.85
9,200.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.80
-9.68%
-0.86
-16.47%
-0.84
21.83%
-0.84
-9.62%
-0.57
28.50%
-0.85
1.78%
-0.86
-2.44%
-0.87
-2.72%
-0.89
-55.01%
Revenue
Q2Q % growth
3.4M27.863MN/AN/AN/AN/A
EBITDA
Q2Q % growth
-37.006M
32.40%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-56.688M
-2.98%
-56.871M
-3.41%
-58.701M
22.56%
-56.237M
-1.15%
-28.776M
49.24%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.77
-11.59%
-0.980.2121.14%
Q2 2025
Q2Q % growth
-1.07
-42.67%
-0.85-0.22-25.93%
Q1 2025
Q2Q % growth
-0.74
13.95%
-0.820.089.46%
Q4 2024
Q2Q % growth
-0.73
-35.19%
-0.770.045.54%
Q3 2024
Q2Q % growth
-0.69
24.18%
-0.820.1316.07%
Q2 2024
Q2Q % growth
-0.75
8.54%
-0.74-0.01-1.34%
Q1 2024
Q2Q % growth
-0.86
39.44%
-1.010.1514.81%
Q4 2023
Q2Q % growth
-0.54
8.47%
-0.980.4444.93%
Q3 2023
Q2Q % growth
-0.91
-68.52%
-0.940.033.20%
Q2 2023
Q2Q % growth
-0.82
-121.75%
-0.990.1717.12%
Q1 2023
Q2Q % growth
-1.42
-425.93%
-1.00-0.42-42.06%
Q4 2022
Q2Q % growth
-0.59
20.27%
-0.680.0913.02%
Q3 2022
Q2Q % growth
-0.54
-35.00%
-0.990.4545.23%
Q2 2022
Q2Q % growth
3.77
1,147.22%
5.53-1.76-31.76%
Q1 2022
Q2Q % growth
-0.27 -0.620.3556.61%
Q4 2021
Q2Q % growth
-0.74
74.13%
-0.48-0.26-53.27%
Q3 2021
Q2Q % growth
-0.40 -0.430.037.36%
Q2 2021
Q2Q % growth
-0.36 -0.420.0614.95%
Q1 2021
Q2Q % growth
0.00 0.07-0.07-100.00%
Q4 2020
Q2Q % growth
-2.86 -0.39-2.47-628.29%
CGEM Yearly EPS VS EstimatesCGEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2022
Q2Q % growth
280.5M-280.5M-100.00%
Q1 2022
Q2Q % growth

-100.00%
%
Q1 2021
Q2Q % growth
18.94M 19.38M-440K-2.27%
Q4 2020
Q2Q % growth
9.18M-9.18M-100.00%
CGEM Yearly Revenue VS EstimatesCGEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS4.01% 11.25% 6.33% 4.26%
RevenueN/A N/A N/A N/A